Brief: Nestlé Health Science To Acquire Global Rights To VOWST
06/06/2024 12:53
June 6 (Reuters) - Seres Therapeutics Inc MCRB.O :
* NESTLÉ HEALTH SCIENCE AGREES TO ACQUIRE GLOBAL RIGHTS TO
VOWST®,
PRODUCT IT LAUNCHED IN JUNE 2023
Source text for Eikon: ID:nPn5CWcjra
Further company coverage: MCRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47